Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) EPS (Basic) (2016 - 2025)

InspireMD (NSPR) has 16 years of EPS (Basic) data on record, last reported at -$0.16 in Q3 2025.

  • For Q3 2025, EPS (Basic) changed 0.0% year-over-year to -$0.16; the TTM value through Sep 2025 reached -$0.82, down 13.89%, while the annual FY2024 figure was -$0.76, 7.32% up from the prior year.
  • EPS (Basic) reached -$0.16 in Q3 2025 per NSPR's latest filing, up from -$0.26 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.05 in Q3 2023 and bottomed at -$0.6 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$0.35, with a median of -$0.26 recorded in 2025.
  • Peak YoY movement for EPS (Basic): soared 91.96% in 2021, then tumbled 220.0% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.53 in 2021, then dropped by 13.21% to -$0.6 in 2022, then surged by 78.33% to -$0.13 in 2023, then tumbled by 38.46% to -$0.18 in 2024, then rose by 11.11% to -$0.16 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.16 in Q3 2025, -$0.26 in Q2 2025, and -$0.22 in Q1 2025.